CD274 and breast cancer: This system not only inhibits BC tumor cells and recruits T cells to remodel the tumor immune microenvironment and enhance tumor antigen–specific immune responses, but it also synergizes with PD-L1 blockade to directly kill BC cells, resulting in marked suppression of tumor proliferation, migration, and invasion (Figure 4) (Zhang WQ.